Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1985 Nov;86(3):753–761. doi: 10.1111/j.1476-5381.1985.tb08955.x

The effects of methyl beta-carboline-3-carboxylate on social interaction and locomotor activity when microinjected into the nucleus raphé dorsalis of the rat.

S W Hindley, A Hobbs, I A Paterson, M H Roberts
PMCID: PMC1916738  PMID: 3933600

Abstract

Intraperitoneal and intracerebral injections of methyl beta-carboline-3-carboxylate (beta CCM) and intracerebral injections of RO 15-1788 were given to rats. The performance of the rats in the social interaction test was measured to determine if changes in social interaction induced by beta CCM were mediated in part by the nucleus raphé dorsalis (NRD). Intraperitoneal injections of beta CCM, 2 and 4 mg kg-1, reduced social interaction. Intracerebral microinjections of beta CCM (10-0.1 ng in 0.5 microliter) into the NRD reduced social interaction. Injections outside the NRD did not have this effect. Intracerebral microinjections of RO 15-1788 (1 ng in 0.5 microliters) into the NRD had no effect when given alone, but blocked the reduction in social interaction caused by intracerebral or intraperitoneal injections of beta CCM. No effect was observed when R 15-1788 was microinjected into sites outside the NRD. Changes in social interaction may reflect changes in anxiety. The NRD may be one of the important sites for the expression of the anxiogenic actions of beta CCM.

Full text

PDF
753

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balfour D. J. Effects of GABA and diazepam on 3H-serotonin release from hippocampal synaptosomes. Eur J Pharmacol. 1980 Nov 7;68(1):11–16. doi: 10.1016/0014-2999(80)90054-0. [DOI] [PubMed] [Google Scholar]
  2. Bonetti E. P., Pieri L., Cumin R., Schaffner R., Pieri M., Gamzu E. R., Müller R. K., Haefely W. Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects. Psychopharmacology (Berl) 1982;78(1):8–18. doi: 10.1007/BF00470579. [DOI] [PubMed] [Google Scholar]
  3. Braestrup C., Nielsen M. GABA reduces binding of 3H-methyl beta-carboline-3-carboxylate to brain benzodiazepine receptors. Nature. 1981 Dec 3;294(5840):472–474. doi: 10.1038/294472a0. [DOI] [PubMed] [Google Scholar]
  4. Braestrup C., Nielsen M., Honoré T., Jensen L. H., Petersen E. N. Benzodiazepine receptor ligands with positive and negative efficacy. Neuropharmacology. 1983 Dec;22(12B):1451–1457. doi: 10.1016/0028-3908(83)90113-2. [DOI] [PubMed] [Google Scholar]
  5. Clark S. L., Edeson R. O., Ryall R. W. The relative significance of spinal and supraspinal actions in the antinociceptive effect of morphine in the dorsal horn: an evaluation of the microinjection technique. Br J Pharmacol. 1983 Jul;79(3):807–818. doi: 10.1111/j.1476-5381.1983.tb10019.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Corda M. G., Blaker W. D., Mendelson W. B., Guidotti A., Costa E. beta-Carbolines enhance shock-induced suppression of drinking in rats. Proc Natl Acad Sci U S A. 1983 Apr;80(7):2072–2076. doi: 10.1073/pnas.80.7.2072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dorow R., Horowski R., Paschelke G., Amin M. Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors. Lancet. 1983 Jul 9;2(8341):98–99. doi: 10.1016/s0140-6736(83)90076-4. [DOI] [PubMed] [Google Scholar]
  8. File S. E., Lister R. G., Nutt D. J. The anxiogenic action of benzodiazepine antagonists. Neuropharmacology. 1982 Oct;21(10):1033–1037. doi: 10.1016/0028-3908(82)90118-6. [DOI] [PubMed] [Google Scholar]
  9. File S. E. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Methods. 1980 Jun;2(3):219–238. doi: 10.1016/0165-0270(80)90012-6. [DOI] [PubMed] [Google Scholar]
  10. Gallager D. W. Benzodiazepines: potentiation of a GABA inhibitory response in the dorsal raphe nucleus. Eur J Pharmacol. 1978 May 15;49(2):133–143. doi: 10.1016/0014-2999(78)90069-9. [DOI] [PubMed] [Google Scholar]
  11. Graeff F. G. Minor tranquilizers and brain defense systems. Braz J Med Biol Res. 1981 Oct;14(4-5):239–265. [PubMed] [Google Scholar]
  12. Jacobs B. L., Foote S. L., Bloom F. E. Differential projections of neurons within the dorsal raphe nucleus of the rat: a horseradish peroxidase (HRP) study. Brain Res. 1978 May 19;147(1):149–153. doi: 10.1016/0006-8993(78)90779-5. [DOI] [PubMed] [Google Scholar]
  13. Paterson I. A., Roberts M. H. Methyl-beta-carboline-3-carboxylate attenuates GABA effects in rat brain hippocampus in vivo. Brain Res. 1983 Nov 14;278(1-2):274–278. doi: 10.1016/0006-8993(83)90253-6. [DOI] [PubMed] [Google Scholar]
  14. Prado de Carvalho L. P., Grecksch G., Chapouthier G., Rossier J. Anxiogenic and non-anxiogenic benzodiazepine antagonists. Nature. 1983 Jan 6;301(5895):64–66. doi: 10.1038/301064a0. [DOI] [PubMed] [Google Scholar]
  15. Shibata K., Kataoka Y., Gomita Y., Ueki S. Localization of the site of the anticonflict action of benzodiazepines in the amygdaloid nucleus of rats. Brain Res. 1982 Feb 25;234(2):442–446. doi: 10.1016/0006-8993(82)90884-8. [DOI] [PubMed] [Google Scholar]
  16. Thiébot M. H., Hamon M., Soubríe P. Attenuation of induced-anxiety in rats by chlordiazepoxide: role of raphe dorsalis benzodiazepine binding sites and serotoninergic neurons. Neuroscience. 1982;7(9):2287–2294. doi: 10.1016/0306-4522(82)90139-7. [DOI] [PubMed] [Google Scholar]
  17. Wise C. D., Berger B. D., Stein L. Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the brain. Science. 1972 Jul 14;177(4044):180–183. doi: 10.1126/science.177.4044.180. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES